Thursday, 22nd April 2021, 11:00am-12:00pm
The National Institute for Health and Care Excellence (NICE) is a world leading producer of high quality evidence syntheses to inform the development of national guidelines. Our aim is to facilitate links to the underpinning evidence and support shared decision making between patients and professionals through use of interactive, living guideline recommendations. To realise this vision NICE is committed to developing collaborative links with organisations such as Cochrane, wherever feasible, to support timely production, uptake and reduced duplication of high quality evidence syntheses.
This session will explore the opportunities, challenges and mechanisms that are in place to support mutually beneficial collaborative efforts. We will illustrate with a recent example where NICE worked with the Cochrane Tobacco Addiction Group to support the update of the ‘Tobacco: preventing uptake, promoting quitting and treating dependence’ guideline. Perspectives on collaboration will be provided from the viewpoint of the NICE developer, the Cochrane reviewers, and the NICE Guideline committee.
Senior Technical Analyst, Methods and Economics Team, Centre for Guidelines at NICE
Chair of one of the standing NICE Public Health Advisory Committees
Deputy Editor in Chief, Cochrane Library